Illumina, Inc. (ILMN) Financials

ILMN Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 6.6 billion 3.9 billion
Dec. 31, 2025 6.6 billion 3.9 billion
Sept. 30, 2025 6.2 billion 3.8 billion
June 30, 2025 6.1 billion 3.8 billion

ILMN Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 251.0 million ?
Dec. 31, 2025 267.0 million 63.0 million
Sept. 30, 2025 260.0 million 70.0 million
June 30, 2025 211.0 million -73.0 million

ILMN Net Income

No data available :(

ILMN Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.2 billion 1.5 billion 475.0 million
Dec. 31, 2025 1.6 billion 1.5 billion 564.0 million
Sept. 30, 2025 1.3 billion 994.0 million 506.0 million
June 30, 2025 1.2 billion 1.5 billion 528.0 million

ILMN Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 154.0 million
Dec. 31, 2025 154.0 million
Sept. 30, 2025 154.0 million
June 30, 2025 157.0 million

ILMN Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 38.0 million 240.0 million 272.0 million -
Dec. 31, 2025 54.0 million 238.0 million 283.0 million -
Sept. 30, 2025 24.0 million 228.0 million 273.0 million -
June 30, 2025 23.0 million 243.0 million 252.0 million -

ILMN Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.1 billion 347.0 million
Dec. 31, 2025 1.2 billion 382.0 million
Sept. 30, 2025 1.1 billion 351.0 million
June 30, 2025 1.1 billion 340.0 million

ILMN Revenue by Segment

Graph available only for paid members. Upgrade to see it.

ILMN

Price: $168.06

52 week price:
73.86
170.93

Payout Ratio Range:
0.48%
5662.89%

Earnings Per Share: 5.49 USD

P/E Ratio: 25.97

Exchange: NMS

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 1.1 million

Ebitda: 273.0 million

Market Capitalization: 21.6 billion

Links: